• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      Ape-directory
      AVCJ Private Equity Online Directory

      With its wide network of senior industry contacts, the directory is the most comprehensive online directory on private equity and venture capital in Asia. It is easy to navigate, enabling access to Asian private equity firms and professionals.

      Read more
      2016-china-cover
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

prenetics-ipo
SPAC target Prenetics sinks on US debut

Hong Kong-based genomic and diagnostic testing business Prenetics slumped on its NASDAQ debut, unable to withstand struggling public markets public markets and weak investor appetite for businesses that merge with US-listed special purpose acquisition...

  • Greater China
  • 20 May 2022
drugs2
India's Multiples invests $88m in BDR Pharma

Multiples Private Equity has led a consortium in the acquisition of a 9.3% stake in India’s BDR Pharmaceuticals for INR 6.8bn (USD 88.5m).

  • South Asia
  • 18 May 2022
medicine-pills-drug-healthcare-doctor
Japan Industrial Solutions supports troubled local drug maker

Japan Industrial Solutions (JIS) has agreed to invest up to JPY 20bn (USD 155m) in Japan-based generic drug manufacturer Nichi-Iko Pharmaceutical with a view to saving the troubled company.

  • North Asia
  • 18 May 2022
doctor-operation-surgery-surgeon-healthcare-medical-hospital
Eight Roads launches $250m India healthcare fund

Eight Roads Ventures has launched its first dedicated healthcare and life-sciences fund for India with a corpus of USD 250m provided entirely by its parent, Fidelity.

  • South Asia
  • 17 May 2022
x-ray-imed-diagnostic
ICG buys New Zealand's Canopy Healthcare

ICG has acquired Canopy Healthcare Group, a New Zealand-based healthcare platform that offers diagnostic imaging, medical oncology, and drug compounding services.

  • Australasia
  • 16 May 2022
pharmaceuticals-drugs-medicine
PAG backs acquisition of India's Optimus Drugs

PAG has supported the acquisition of Optimus Drugs for an undisclosed sum alongside CX Partners and Samara Capital as part of a joint Indian pharmaceuticals platform play.

  • South Asia
  • 15 May 2022
healthcare-stethoscope
MDI launches healthcare fund with Indonesian strategic

MDI Ventures, the corporate VC arm of state-controlled Telkom Indonesia, has launched a USD 20m fund with domestic vaccine manufacturer Bio Farma that will pursue early and growth-stage healthcare investments.

  • Southeast Asia
  • 13 May 2022
pharma-drugs-pills
China biotech player Reistone raises $100m

Reistone, a novel drug developer incubated by Jiangsu Hengrui Pharmaceuticals, has raised a Series A of nearly USD 100m led by Huagai Capital.

  • Greater China
  • 13 May 2022
india-eye-health
TPG, Temasek invest $136m in India's Dr Agarwal’s

TPG Growth and Temasek Holdings have invested a combined INR 10.5bn (USD 136m) in Indian eyecare chain Dr. Agarwal’s Eye Hospital, setting up an exit for ADV Partners.

  • South Asia
  • 12 May 2022
diagnostics-india
LeapFrog leads $61m investment in India's Redcliffe Lifetech

LeapFrog Investments has led a USD 61m round for India’s Redcliffe Lifetech, a diagnostics platform focused on non-communicable diseases, including heart disease, cancer, and diabetes.

  • South Asia
  • 10 May 2022
doctor-operation-surgery-surgeon-healthcare-medical-hospital
IDG backs China surgical robot start-up

IDG Capital has joined a Series A round of several hundred million renminbi for China’s Sustao, which is developing a platform for fully automating surgical robots.

  • Greater China
  • 06 May 2022
aligner-braces
India dental start-up Toothsi raises $40m Series C

India’s Toothsi, a direct-to-consumer start-up that makes own-branded transparent dental aligners and braces, has raised a USD 40m Series C round featuring Eight Roads Ventures.

  • South Asia
  • 04 May 2022
ryan-collins-massmutual-ventures
Fund focus: MassMutual Ventures widens remit

Having started a Southeast Asia specialist, MassMutual Ventures has broadened its regional coverage to include everything outside of China. Europe is also part of the equation for Fund III

  • Southeast Asia
  • 03 May 2022
vaccines-healthcare-drug-pharma
Singapore mRNA vaccine developer raises $140m

RVAC Medicines, a Singapore-based company involved in developing messenger RNA (mRNA) vaccines for COVID-19, has closed a Series B round that takes its overall funding to USD 140m.

  • Greater China
  • 29 April 2022
healthcare-medical-app
Quadria eyes $1b for Fund III, emphasizes health-tech

South and Southeast Asia healthcare specialist Quadria Capital is broadening its scope to include areas such as healthcare technology and digital health insurance for Fund III, which is expected to be up to USD 1bn in size.

  • South Asia
  • 28 April 2022
dollar-bill-money-2
MassMutual Ventures raises $300m for Asia, Europe

MassMutual Ventures (MMV), a global venture capital firm that counts US-based Massachusetts Mutual Life Insurance as its sole LP, has launched a USD 300m fund that will invest in Asia Pacific and Europe.

  • Fundraising
  • 28 April 2022
healthcare-stethoscope
General Atlantic leads $300m Series D for Biofourmis

Biofourmis, a Singapore founded and now US-based operator of a health analytics platform, has achieved unicorn status with the closing of a USD 300m Series D round led by General Atlantic.

  • Southeast Asia
  • 27 April 2022
endoscope
Vision Fund backs Japan's AI Medical Service

SoftBank Vision Fund 2 has led a JPY 8bn (USD 70m) Series C funding round for AI Medical Service, a Tokyo-based medical technology company that has developed an artificial intelligence-enabled (AI) endoscopy diagnostic solution.

  • North Asia
  • 27 April 2022
novotech
China digital CRO Elixir raises $52m

Elixir, a China-based clinical research organisation (CRO), has raised a USD 52m Series A round from Lyfe Capital, Chow Tai Fook Investment, and Sinovation Ventures.

  • Greater China
  • 26 April 2022
virus-pharma-drugs
China virotherapy specialist Binhui Biopharm raises $47m

Binhui Biopharm, a Chinese biotech firm specialising in oncolytic virus immune-oncology, has raised CNY 300m (USD 47m) in an extended Series B round led by Yangtze River Pharmaceutical Group.

  • Greater China
  • 25 April 2022
hospital-surgery-nurse
KKR pursues $15b Australia healthcare take-private

A KKR-led consortium has proposed to acquire Ramsay Health Care, an Australia-listed hospital operator with a footprint that encompasses Australia, Europe, and other parts of Asia, at a valuation of approximately AUD 20.1bn (USD 14.9bn).

  • Australasia
  • 21 April 2022
india-map
Creaegis targets $500m India fund

Creaegis, an India-based private equity firm established by Prakash Parthasarathy, formerly founding CIO and managing partner of PremjiInvest, is looking to raise USD 500m for its debut fund.

  • South Asia
  • 20 April 2022
pharma-drugs-pills
China stem cell drug developer Baylx raises $47m

Baylx, a Beijing-based drug developer that utilises stem cell technology, has raised CNY 300m (USD 47m)across two rounds - a Series B and a Series B extension.

  • Greater China
  • 20 April 2022
doctor-operation-surgery-surgeon-healthcare-medical-hospital
Lighthouse leads $65m round for India's Medikabazaar

Lighthouse Funds has led a USD 65m funding round for Medikabazaar, an India-based B2B medical supplies marketplace, at a valuation of USD 700m.

  • South Asia
  • 19 April 2022
1 2 3

Most read

lidar
Ince leads $30m round for China’s PhiGent Robotics
usd-rmb-dollar-renminbi
China's BlueRun $819m across US dollar, renminbi funds
singapore-harbor-cityscape-night-2
Singapore's Azalea targets $754m PE-backed bond offering
hong-kong-dayjpg11
Hong Kong's Betatron hits $15m first close on VC fund
fundraising-money-hand-coins
SBI, Kyobo Life seek $75m for Asia VC fund
  • About AVCJ
  • Advertise
  • Contacts
  • About Acuris
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013